Claim this page free
AI visibility score
1.13/ 10Near-invisible

▲ 0.03 since Nov 2026

As of 2026-11-09 · Engagemii IndexCheck another site →Live terminal →

AI Visibility Scorecard

CINQAIR® (reslizumab) Injection

CINQAIR® (reslizumab) Injection

Unclaimed

cinqair.com · Healthcare

At 1.13/10, CINQAIR® (reslizumab) Injection is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are Structured Data, Backlinks and Domain Authority. That is fixable, and the signals below show where to start.

AI engines read this profile 1 times

Claude

7

AI Naming Predictability

i

Rarely named · 7/100

Healthcare average 11

Top 55% of Healthcare

See what's behind this score →

1.13

AEO Visibility

i

Near-invisible · 1.13/10

Healthcare average 1.5

See what's behind this score →

-

Network Authority

i

Not connected yet

0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.

See what's behind this score →

5

Muse Index Score

i

AI agent readiness

Basic · 5/100

Healthcare average 18

See what's behind this score →

0

AI Adoption

i

None detected · 0/100

Healthcare average 0

See what's behind this score →

Share

About CINQAIR® (reslizumab) Injection

from our crawl and measurement

CINQAIR® (reslizumab) Injection is a business whose own site puts it this way: "Information for patients with severe eosinophilic asthma about CINQAIR therapy and about support services for prescribed patients." When AI engines look at it, they find little to work with. It scores 1.13 out of 10.

Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.

AI crawlers have read this profile once in our tracking, including ClaudeBot (Anthropic).

Company ·
CINQAIR® (reslizumab) Injection
Website ·
cinqair.com
Industry ·
Healthcare
Site status ·
Live (The website showed an active business site when last checked (Nov 1, 2026).)
Last scored ·
Nov 9, 2026

The 6 on-page signals AI reads

Strong · Good · Fair · Weak

Structured Data

Weak

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Strong

Clear headings and answer-style content.

Entity Clarity

Fair

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Fair

Experience, Expertise, Authority, Trust markers.

Technical AEO

Good

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Fair

Sitemaps and entity links AI can follow.

The 6 off-page signals AI reads

How the web signals your brand to AI

Backlinks

Weak

No inbound links found yet.

Domain Authority

Weak

Little domain authority yet.

Reference Presence

-

Not yet measured.

News & Press

Weak

No press coverage found yet.

Community

Weak

No community discussion yet.

Social Mentions

Weak

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 1.13/10, CINQAIR® (reslizumab) Injection is near-invisible to AI engines today. That is fixable, and the signals above are where to start.

Picked for CINQAIR® (reslizumab) Injection: AEO & AI Search

Why your brand doesn't show up in ChatGPT answers (and how to fix it)

ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.

Continue reading in your free Engagemii portal

Sign up free to read the full article and get your AEO fix list for CINQAIR® (reslizumab) Injection.

Source & Attribution

Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/cinqair

Cite this score: Engagemii (2026). "AEO Score for CINQAIR® (reslizumab) Injection." Retrieved from https://engagemii.com/aeo/brands/cinqair

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform